C12N 2795/18171
Demonstrated in vivo effect
C12N2795/18171 (Demonstrated in vivo effect) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 5
- Assignees
- 3
- Inventors
- 10
- Latest grant
- 14 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 3 |
By publication year.
Recent patents
- Immunotherapy compositions and methods for treatment of tauopathy and transgenic mouse12 Sep 2024US 2024/0299512 A1UNM Rainforest Innovations
- Immunotherapy compositions and methods for treatment of tauopathy and transgenic mouse20 Jun 2024US 2024/0197845 A1UNM Rainforest Innovations
- Baceriophage virus-like particles vaccines for chlamydia trachomatis infections16 May 2024US 2024/0156937 A1UNM Rainforest Innovations
- Compositions and methods of treating cancer and infections using bacteriophage and its mutants20 Aug 2020US 2020/0261559 A1Board of Trustees of Michigan State University
- Immunotherapy compositions and methods for treatment of tauopathy and transgenic mouse22 Feb 2018US 2018/0050097 A1Stc. Unm
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.